Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2025.205 | Clinical and mechanistic investigation of the cross reactivity of antibodies against emerging viral variants to facilitate vaccine design | Prof. CHEUNG Peter |
| 2025.206 | 3D Printed Temporal Bone Models in Surgical Training: A Prospective Randomized Controlled Trial | Dr Lau Eric Hui Lun |
| 2025.207 | Unraveling the role of cancer-associated fibroblasts-originated Slit3 in gastric carcinogenesis by promoting self-renewal and boosting fibroblast-neuron conversion | Prof. KANG Wei |
| 2025.208 | Concomitant Endoscopic Third Ventriculostomy (ETV) and Endoscopic Tumour Biopsy (ETB): A review of 70 cases |
Dr. ZHU Xian Lun Xian Lun Zhu |
| 2025.210 | Embracing Artificial Intelligence-Assisted Upper and Lower Urinary Tract Assessment in Primary Care and Nurse Clinic Settings | Prof. TEOH Jeremy Yuen Chun |
| 2025.211 | Vision-language-based deep learning models for emergency department patients screening and diagnosis | Prof. CHU Winnie Chiu Wing |
| 2025.213 | Deep Learning–Augmented multivariable CUSUM Analysis for Three-Phase Learning Curves in Endobronchial Ablation Procedures |
Prof. NG Calvin Sze Hang 吳士衡 |
| 2025.214 | Investigating the Prevalence of Tendinopathy in Patients with Metabolic Syndrome: The Impact of Metabolic Drugs | Prof. LUI Pauline Po Yee |
| 2025.215 | Validity of Chinese version of Barthel Index - dyspnea (BI-d) | Dr. SIU Chi Hong |
| 2025.216 | Validation of Cantonese version of SCID-5-RV for anxiety disorders module (C-SCID-5-RV-ADM) in Cantonese-speaking Hong Kong Chinese from a regional Common Mental Disorder Clinic | Dr. POON Andrew Wan Sun |
| 2025.217 | Usage, response and tolerance of mTOR inhibitor for Tuberous Sclerosis Complex (TSC) patients in Hong Kong | Dr. Wong Ka Nam |
| 2025.218 | Clinical characteristics and outcomes of patients with Adult-Onset Still’s Disease (AOSD) in Hong Kong | Dr. TAM Lydia Ho Pui |
| 2025.219 | Clinical characteristics and outcomes of patients with Adult-Onset Still’s Disease (AOSD) in Hong Kong | Dr. CHAN Dennis Tin ho |
| 2025.220 | Clinical characteristics and outcomes of patients with Adult-Onset Still’s Disease (AOSD) in Hong Kong | Dr. TANG Hoi San |
| 2025.221 | Retrospective Review of Paediatric Rheumatology Patients Transitioning to Adult care | Dr. Chan Dennis Tin Ho |
| 2025.225 | A descriptive study on safety, tolerability and myopia progression in children with myopia prescribed with 0.01% atropine eye drop | Professor Yam Cheuk Sing Jason |
| 2025.235 | A Phase 3 Study of the Selective Anaplastic Lymphoma Kinase (ALK) Inhibitor NVL-655 Compared to Alectinib in First-Line Treatment of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer (ALKAZAR) | Dr. LOONG Herbert Ho Fung |
| 2025.238 | CAPA in-vitro Oocyte Maturation | Prof. CHUNG Jacqueline Pui Wah |
| 2025.251 | Validating the Chinese "Reading the Mind in the Eyes" Test: Evidence from Hong Kong Neurosurgical Patients (RMET-HK) |
Dr. WOO Peter Yat Ming Yat Ming Peter Woo |
| 2025.256 | The Scope and Impact of Original Clinical Research by Hong Kong Public Healthcare Professionals: A Multi-center Observational Study |
Dr. WOO Peter Yat Ming Yat Ming Peter Woo |
| 9406(S) | A Prospective Randomized Phase III Study Comparing the Combination of Cisplatin, Doxorubicin, Interferon-Alpha-2B and 5-Fluorouracil to Doxorubicin Alone in the Treatment of Inoperable Hepatocellular Carcinoma | Prof. YEO Winnie |
Page 263 of 263.